USG Auratone Acoustical Tile

Product Description

USG Auratone Acoustical Tile was a line of ceiling tile manufactured by the United States Gypsum Corporation (USG) and sold primarily throughout the 1950s into 1974. The product was designed to provide sound absorption and noise control in commercial, institutional, and residential interior spaces. Auratone tiles were marketed to architects, building contractors, and facility managers seeking cost-effective acoustical treatment for offices, schools, hospitals, government buildings, and multi-family housing projects.

The tiles were typically installed in suspended grid ceiling systems or adhered directly to existing ceiling substrates using compatible adhesives. Their combination of acoustic performance and aesthetic finish made them a widely specified product during the postwar construction boom, a period during which USG held a dominant position in the American building materials market. As a result, Auratone tiles were installed across a broad range of building types throughout the United States during the decades they were produced.

Production of Auratone tiles in their asbestos-containing formulation continued until 1974, the period during which regulatory scrutiny of asbestos in building materials was intensifying. Buildings constructed or renovated between the 1950s and the mid-1970s may still contain Auratone tiles, particularly where original ceilings remain undisturbed.

Asbestos Content

USG Auratone Acoustical Tile was manufactured with chrysotile asbestos as a mineral fiber reinforcement component. Chrysotile, the most commercially prevalent form of asbestos used in the United States during the twentieth century, was incorporated into ceiling tile formulations to improve the structural integrity of the finished product, enhance fire resistance, and stabilize the tile matrix during manufacturing and installation.

In acoustical tile production, mineral fibers such as chrysotile were combined with binders and fillers to produce a lightweight, porous panel capable of absorbing sound. Chrysotile’s fibrous structure contributed to the cohesion of the tile and its resistance to crumbling under normal handling. While the tiles in undisturbed, intact condition may have presented limited fiber release under normal use conditions, the material became hazardous when cut, drilled, broken, sanded, or otherwise mechanically disturbed — activities that occurred routinely during installation and renovation.

The Asbestos Hazard Emergency Response Act (AHERA), administered by the U.S. Environmental Protection Agency, established regulatory frameworks for identifying and managing asbestos-containing building materials, including acoustical ceiling tiles of the type manufactured during this era. USG’s use of chrysotile in Auratone tiles is documented through product formulation records, materials testing, and litigation discovery produced over decades of asbestos injury litigation.

How Workers Were Exposed

Occupational exposure to asbestos from USG Auratone Acoustical Tile was concentrated among the tradespeople who handled the tiles directly — primarily during installation, cutting, and demolition or renovation activities.

Acoustical Tile Installers faced the most consistent and direct exposure. Installing ceiling tile routinely required scoring and snapping tiles to fit around obstructions such as light fixtures, HVAC components, and structural elements. Each cut generated airborne chrysotile fibers. Workers performing these tasks in enclosed spaces — common in commercial and institutional construction — inhaled fibers that settled in the lung tissue over years and decades of repeated work.

Ceiling Contractors and their crews worked in sustained proximity to cut and disturbed tile material throughout full workdays on large commercial and institutional projects. Supervisors, helpers, and laborers assisting with tile installation shared the exposure environment even if they were not personally handling tile at every moment.

Renovation Workers frequently encountered Auratone tiles during remodeling and building rehabilitation projects undertaken years or even decades after original installation. Removing or disturbing existing ceiling tiles — whether to update the ceiling system, access overhead utilities, or demolish a space — released accumulated fiber from the tile matrix. OSHA standards governing asbestos in construction (29 CFR 1926.1101) recognize renovation and demolition activities as among the highest-risk scenarios for asbestos fiber release from installed building materials.

The latency period for asbestos-related diseases — the interval between initial exposure and clinical diagnosis — typically ranges from ten to fifty years. Workers exposed to Auratone tiles during installation or renovation work in the 1950s through the 1970s may only now be receiving diagnoses of mesothelioma, asbestosis, lung cancer, or other asbestos-related conditions. This extended latency period is a defining characteristic of asbestos disease and explains why claims related to products manufactured decades ago remain active today.

United States Gypsum Asbestos Settlement Trust

Claims related to asbestos exposure from USG Auratone Acoustical Tile are eligible for submission to the United States Gypsum Asbestos Settlement Trust. This trust was established as part of USG Corporation’s resolution of its asbestos liability through the federal bankruptcy process, a mechanism that created a dedicated fund to compensate individuals harmed by USG asbestos-containing products.

USG Auratone Acoustical Tile is a named product within the trust’s claims documentation framework. Claimants — or their surviving family members in wrongful death cases — may file claims directly against the trust without initiating conventional civil litigation, though litigation pathways may remain available depending on individual circumstances and applicable state law.

Eligible Claim Categories typically recognized by the United States Gypsum Asbestos Settlement Trust include:

  • Mesothelioma — malignant mesothelioma of the pleura, peritoneum, or pericardium
  • Lung Cancer — primary lung cancer with documented asbestos exposure history
  • Asbestosis — radiographically or pathologically confirmed asbestosis
  • Other Asbestos-Related Conditions — including pleural disease meeting trust eligibility criteria

Filing Requirements

Trust claims generally require documentation of the following:

  1. A confirmed diagnosis of a qualifying asbestos-related disease from a licensed medical professional
  2. Exposure history establishing contact with USG Auratone Acoustical Tile specifically, supported by work history records, coworker affidavits, union records, employer documentation, or similar evidence
  3. A showing that the exposure occurred during the product’s documented manufacturing period (1950s–1974)

Consulting an Attorney

Individuals who believe they or a family member were exposed to USG Auratone Acoustical Tile during occupational activities are strongly encouraged to consult an attorney experienced in asbestos trust fund claims. An asbestos attorney can evaluate the available evidence, identify all potentially applicable trusts or litigation defendants, and manage filing deadlines — including statutes of limitations that vary by state and can affect eligibility if not observed.

Trust fund claims may be filed concurrently with or independently of civil litigation, depending on the full scope of a claimant’s exposure history and the other manufacturers or products involved. Workers who handled multiple asbestos-containing products across their careers — a common circumstance in the construction trades — may have claims against multiple trusts or defendants simultaneously.